Insider · CIK 0001689819

Thomas Thomas T.

Reports to the SEC for 1 company · SANTA MONICA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001689819

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−10.4K sh	$20.00	−$208K	2,000
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	$20.00	−$40K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2022-06-14	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	12,375
2021-09-22	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,834 sh	$10.00	+$18.3K	11,110
2021-09-22	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−735 sh	$25.02	−$18.4K	10,375
2021-09-22	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,834 sh	—	—	0
2021-09-21	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$10.00	+$20K	10,107
2021-09-21	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−60 sh	$24.07	−$1,444.2	10,047
2021-09-21	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−771 sh	$24.12	−$18.6K	9,276
2021-09-21	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	1,834
2021-09-14	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+25 sh	$10.00	+$250	6,678
2021-09-14	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−15 sh	$18.95	−$284.25	6,663
2021-09-14	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$10.00	+$15K	8,163
2021-09-14	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−792 sh	$19.06	−$15.1K	7,371
2021-09-14	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$10.00	+$15K	8,871
2021-09-14	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−764 sh	$19.70	−$15.1K	8,107
2021-09-14	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−25 sh	—	—	6,834
2021-09-14	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	5,334
2021-09-14	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	3,834
2021-09-07	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,475 sh	$10.00	+$14.8K	7,475
2021-09-07	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−822 sh	$18.00	−$14.8K	6,653
2021-09-07	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,475 sh	—	—	6,859
2021-08-19	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−600 sh	$16.20	−$9,720	6,400
2021-08-19	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−400 sh	$16.25	−$6,500	6,000
2021-06-15	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	7,000
2021-06-15	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2020-09-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+500 sh	$8.05	+$4,025	5,000
2020-09-03	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+2,500 sh	$8.40	+$21K	4,500
2020-06-15	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	2,000
2020-06-15	OPIANT PHARMACEUTICALS, INC.Common StockA Award	Director	AAward	+2,500 sh	—	—	2,500
2019-06-12	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2018-06-13	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2018-05-18	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$16.50	−$8,250	0
2018-05-17	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$16.40	−$8,200	1,500
2018-05-17	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$16.51	−$8,255	1,000
2018-05-17	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$16.50	−$8,250	500
2018-05-16	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$16.41	−$8,205	2,263
2018-05-16	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−263 sh	$16.17	−$4,252.71	2,000
2018-05-15	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−800 sh	$17.53	−$14K	2,763
2018-05-14	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,500 sh	$18.54	−$64.9K	3,563
2018-05-11	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,063 sh	$10.00	+$70.6K	7,063
2018-05-11	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	8,334
2017-08-29	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+11.7K sh	—	—	23,334
2016-12-13	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+11.7K sh	—	—	11,667

Recent filings

Accepted (ET)
Mar 34
Thomas Thomas T.0001385508-23-000055
SEC(opens sec.gov)
Jun 144
Thomas Thomas T.0001385508-22-000080
SEC(opens sec.gov)
Sep 234
Thomas Thomas T.0001385508-21-000138
SEC(opens sec.gov)
Sep 164
Thomas Thomas T.0001385508-21-000136
SEC(opens sec.gov)

Companies

OPIANT PHARMACEUTICALS, INC.Director

Address

C/O OPIANT PHARMACEUTICALS, INC. 401 WILSHIRE BLVD., 12TH FLOOR

SANTA MONICA, CA, 90401